Additionally, Ginsenoside Rg1 reduces the production of inflammatory cytokines like interleukin 1 (IL-1) and interleukin 18 (IL-18), thereby alleviating NAFLD through its anti-inflammatory function [138]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.